Trilogy Capital Inc. Novartis Ag Transaction History
Trilogy Capital Inc.
- $1.89 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,472Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.18 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$875 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$734 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$596 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...